Isoprenoids as mediators of the biological effects of statins.
Liao
James K
JK
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02139, USA. jliao@rics.bwh.harvard.edu
D002318:Cardiovascular Diseases / Q000188:drug therapy; D002784:Cholesterol / Q000378:metabolism; D002986:Clinical Trials as Topic; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D011106:Polyisoprenyl Phosphates / Q000378:metabolism*; D017368:Protein Prenylation
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011106:Polyisoprenyl Phosphates; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases